AMG 232

KRT-232 · Amgen

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AMG 232, covering 2025-11-13 to 2025-11-13. Get the full timeline:

Most recent: Clinical Trial Update: Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer [Phase 1]